Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 955,996 | 600,889 | 605,378 | 242,493 | 315,471 |
| Marketable Securities | 8,715 | 437,137 | 172,266 | 389,564 | 715,005 |
| Receivables | 298,653 | 248,968 | 203,623 | 158,043 | 216,645 |
| Inventories | 166,201 | 162,383 | 127,475 | 118,259 | 104,994 |
| TOTAL | $1,555,849 | $1,571,423 | $1,194,369 | $982,257 | $1,426,237 |
| Non-Current Assets | |||||
| PPE Net | 708,664 | 693,673 | 698,354 | 684,756 | 580,248 |
| Intangibles | 3,287,973 | 3,376,369 | 4,257,516 | 4,302,280 | 4,429,583 |
| Other Non-Current Assets | 308,143 | 286,674 | 321,095 | 257,580 | 248,816 |
| TOTAL | $4,304,780 | $4,356,716 | $5,276,965 | $5,244,616 | $5,258,647 |
| Total Assets | $5,860,629 | $5,928,139 | $6,471,334 | $6,226,873 | $6,684,884 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 249,153 | 50,000 | 0 | N/A |
| Accounts payable and accrued liabilities | 175,868 | 89,572 | 78,816 | 74,916 | 67,829 |
| Accrued Expenses | 416,473 | 328,292 | 341,683 | 299,216 | 398,556 |
| Other current liabilities | 15,220 | 37,765 | 14,823 | 10,249 | 30,973 |
| TOTAL | $641,152 | $732,187 | $514,701 | $412,747 | $517,068 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 50,000 | N/A |
| Other Non-Current Liabilities | 2,818,425 | 2,793,703 | 2,811,328 | 2,720,964 | 2,780,180 |
| TOTAL | $2,818,425 | $2,793,703 | $2,811,328 | $2,770,964 | $2,780,180 |
| Total Liabilities | $3,459,577 | $3,525,890 | $3,326,029 | $3,183,711 | $3,297,248 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 190,888 | 185,755 | 181,531 | 178,217 | 174,117 |
| Common Shares | 1,909 | 1,857 | 1,815 | 1,780 | 1,738 |
| Retained earnings | -4,705,981 | -4,498,032 | -3,469,175 | -3,265,026 | -2,641,520 |
| Other shareholders' equity | 2,358 | -944 | 1,428 | -5,236 | -1,443 |
| TOTAL | $2,401,052 | $2,402,249 | $3,145,305 | $3,043,162 | $3,387,636 |
| Total Liabilities And Equity | $5,860,629 | $5,928,139 | $6,471,334 | $6,226,873 | $6,684,884 |